11 July, 2023NodThera is first to demonstrate reduction in neuroinflammation in the clinic with brain penetrant NLRP3 inflammasome inhibitor
7 June, 2023Mozart Therapeutics raises $25 million in expanded Series A financing to support clinical development of first-in-class CD8 Treg modulators for the treatment of autoimmune diseases